BridgeBio Pharma, Correlations
| 2CL Stock | EUR 53.30 10.22 16.09% |
The current 90-days correlation between BridgeBio Pharma, and Tyson Foods is -0.18 (i.e., Good diversification). The correlation of BridgeBio Pharma, is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
BridgeBio Pharma, Correlation With Market
Poor diversification
The correlation between BridgeBio Pharma and DJI is 0.66 (i.e., Poor diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding BridgeBio Pharma and DJI in the same portfolio, assuming nothing else is changed.
BridgeBio |
The ability to find closely correlated positions to BridgeBio Pharma, could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace BridgeBio Pharma, when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back BridgeBio Pharma, - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling BridgeBio Pharma to buy it.
Moving together with BridgeBio Stock
| 0.7 | VX1 | Vertex Pharmaceuticals Earnings Call This Week | PairCorr |
| 0.73 | UNC | UCB SA | PairCorr |
| 0.65 | ASJA | ASTRA INTERNATIONAL | PairCorr |
| 0.68 | ASJA | ASTRA INTERNATIONAL | PairCorr |
| 0.65 | 943 | FREY EO 250 | PairCorr |
| 0.7 | 2OJ | Roscan Gold | PairCorr |
| 0.85 | TUI1 | TUI AG Earnings Call This Week | PairCorr |
| 0.88 | JUN3 | Jungheinrich AG ONVZO | PairCorr |
| 0.65 | WWR | Woolworths Group | PairCorr |
| 0.64 | LLD2 | Lloyds Banking Group | PairCorr |
| 0.67 | PZX | Ping An Insurance | PairCorr |
Moving against BridgeBio Stock
| 0.6 | DUL | Alnylam Pharmaceuticals Earnings Call This Week | PairCorr |
| 0.4 | 1AE | Argen X | PairCorr |
| 0.38 | ISM | PT Indofood Sukses | PairCorr |
| 0.78 | BDD | CONICO LTD Split | PairCorr |
| 0.41 | SOBA | ATT Inc | PairCorr |
Related Correlations Analysis
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between BridgeBio Stock performing well and BridgeBio Pharma, Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze BridgeBio Pharma,'s multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.| Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
|---|---|---|---|---|---|---|---|---|---|---|
| BAC | 1.08 | 0.26 | 0.12 | (0.42) | 1.01 | 1.67 | 9.94 | |||
| T4H | 1.31 | 0.42 | 0.26 | 1.47 | 0.73 | 2.00 | 28.09 | |||
| SIT4 | 1.42 | 0.22 | 0.06 | (0.63) | 1.58 | 3.67 | 9.74 | |||
| SMA | 1.02 | 0.09 | 0.00 | (0.53) | 1.82 | 1.96 | 13.96 | |||
| TF7A | 1.23 | 0.36 | 0.25 | 5.56 | 0.85 | 3.37 | 8.31 | |||
| ISHA | 2.53 | 0.22 | 0.04 | 23.37 | 2.78 | 6.35 | 17.73 | |||
| BWGA | 1.02 | (0.09) | 0.00 | (0.33) | 0.00 | 2.50 | 6.97 | |||
| CAO | 0.70 | 0.01 | (0.05) | (0.40) | 0.92 | 1.88 | 6.39 |
Be your own money manager
Our tools can tell you how much better you can do entering a position in BridgeBio Pharma, without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Correlation Analysis Now
Correlation AnalysisReduce portfolio risk simply by holding instruments which are not perfectly correlated |
| All Next | Launch Module |
BridgeBio Pharma, Corporate Management
Elected by the shareholders, the BridgeBio Pharma,'s board of directors comprises two types of representatives: BridgeBio Pharma, inside directors who are chosen from within the company, and outside directors, selected externally and held independent of BridgeBio. The board's role is to monitor BridgeBio Pharma,'s management team and ensure that shareholders' interests are well served. BridgeBio Pharma,'s inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, BridgeBio Pharma,'s outside directors are responsible for providing unbiased perspectives on the board's policies.
| MBA CPC | Chief Officer | Profile | |
| Richard Scheller | Chairman of Research and Development, Director | Profile | |
| Maricel Apuli | Chief Officer | Profile | |
| Eli Wallace | Chief Oncology | Profile | |
| Michael Henderson | Chief Business Officer | Profile | |
| Andrew Lo | Independent Director | Profile |